Cyprus and Ireland add Prevenar to vaccination schedules
This article was originally published in Scrip
Executive Summary
Cyprus and Ireland have added Prevenar, Wyeth's pneumococcal conjugate vaccine, to their national immunisation schedules. 26 countries now include the vaccine in their national immunisation programmes. The WHOrecommends that governments prioritise the inclusion of the pentavalent pneumococcal conjugate vaccine in their immunisation programmes. Pneumococcal disease results in 1.6 million deaths each year, one million of which are child deaths. Prevenar is the only licensed pneumococcal conjugate vaccine and is now available in 88 countries; more than 180 million doses have been distributed, Wyeth says.
You may also be interested in...
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
German HTA Queries Polivy Benefits Amid Lack Of Evidence
Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.